Articles producció científica> Medicina i Cirurgia

Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism

  • Identification data

    Identifier: imarina:9262900
    Authors:
    Jimenez, DavidRodriguez, CarmenLeon, FranciscoJara-Palomares, LuisLopez-Reyes, RaquelRuiz-Artacho, PedroElias, TeresaOtero, RemediosGarcia-Ortega, AlbertoRivas-Guerrero, AgustinaAbelaira, JaimeJimenez, SoniaMuriel, AlfonsoMorillo, RaquelBarrios, DeisyLe Mao, RaphaelYusen, Roger D.Bikdeli, BehnoodMonreal, ManuelLuis Lobo, JoseIPEP Investigators
    Abstract:
    Background The length of hospital stay (LOS) for acute pulmonary embolism (PE) varies considerably. Whether the upfront use of a PE prognostic assessment and management pathway is effective in reducing the LOS remains unknown.Methods We conducted a randomised controlled trial of adults hospitalised for acute PE: patients were assigned either to a prognostic assessment and management pathway involving risk stratification followed by predefined criteria for mobilisation and discharge (intervention group) or to usual care (control group). The primary end-point was LOS. The secondary end-points were the cost of prognostic tests and of hospitalisation, and 30-day clinical outcomes.Results Of 500 patients who underwent randomisation, 498 were included in the modified intention-to-treat analysis. The median LOS was 4.0 days (interquartile range (IQR) 3.7-4.2 days) in the intervention group and 6.1 days (IQR 5.7-6.5 days) in the control group (p<0.001). The mean total cost of prognostic tests was EUR 174.76 in the intervention group, compared with EUR 233.12 in the control group (mean difference EUR -58.37, 95% CI EUR -84.34 to -32.40). The mean total hospitalisation cost per patient was EUR 2085.66 in the intervention group, compared with EUR 3232.97 in the control group (mean difference EUR -1147.31, 95% CI EUR -1414.97 to -879.65). No significant differences were observed in 30-day readmission (4.0% versus 4.8%), all-cause mortality (2.4% versus 2.0%) or PE-related mortality (0.8% versus 1.2%) rates.Conclusions The use of a prognostic assessment and management pathway was effective in reducing the LOS for acute PE.
  • Others:

    Author, as appears in the article.: Jimenez, David; Rodriguez, Carmen; Leon, Francisco; Jara-Palomares, Luis; Lopez-Reyes, Raquel; Ruiz-Artacho, Pedro; Elias, Teresa; Otero, Remedios; Garcia-Ortega, Alberto; Rivas-Guerrero, Agustina; Abelaira, Jaime; Jimenez, Sonia; Muriel, Alfonso; Morillo, Raquel; Barrios, Deisy; Le Mao, Raphael; Yusen, Roger D.; Bikdeli, Behnood; Monreal, Manuel; Luis Lobo, Jose;IPEP Investigators
    Department: Medicina i Cirurgia
    URV's Author/s: Porras Ledantes, Jose Antonio
    Keywords: Outpatient Mortality Early mobilization Costs Burden
    Abstract: Background The length of hospital stay (LOS) for acute pulmonary embolism (PE) varies considerably. Whether the upfront use of a PE prognostic assessment and management pathway is effective in reducing the LOS remains unknown.Methods We conducted a randomised controlled trial of adults hospitalised for acute PE: patients were assigned either to a prognostic assessment and management pathway involving risk stratification followed by predefined criteria for mobilisation and discharge (intervention group) or to usual care (control group). The primary end-point was LOS. The secondary end-points were the cost of prognostic tests and of hospitalisation, and 30-day clinical outcomes.Results Of 500 patients who underwent randomisation, 498 were included in the modified intention-to-treat analysis. The median LOS was 4.0 days (interquartile range (IQR) 3.7-4.2 days) in the intervention group and 6.1 days (IQR 5.7-6.5 days) in the control group (p<0.001). The mean total cost of prognostic tests was EUR 174.76 in the intervention group, compared with EUR 233.12 in the control group (mean difference EUR -58.37, 95% CI EUR -84.34 to -32.40). The mean total hospitalisation cost per patient was EUR 2085.66 in the intervention group, compared with EUR 3232.97 in the control group (mean difference EUR -1147.31, 95% CI EUR -1414.97 to -879.65). No significant differences were observed in 30-day readmission (4.0% versus 4.8%), all-cause mortality (2.4% versus 2.0%) or PE-related mortality (0.8% versus 1.2%) rates.Conclusions The use of a prognostic assessment and management pathway was effective in reducing the LOS for acute PE.
    Thematic Areas: Saúde coletiva Respiratory system Pulmonary and respiratory medicine Nutrição Medicine (miscellaneous) Medicina iii Medicina ii Medicina i Interdisciplinar General medicine Engenharias iv Educação física Ciências biológicas iii Ciências biológicas ii Biotecnología
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    Author's mail: joseantonio.porras@urv.cat
    Author identifier: 0000-0001-6418-1822
    Record's date: 2024-09-07
    Papper version: info:eu-repo/semantics/acceptedVersion
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Papper original source: European Respiratory Journal. 59 (2):
    APA: Jimenez, David; Rodriguez, Carmen; Leon, Francisco; Jara-Palomares, Luis; Lopez-Reyes, Raquel; Ruiz-Artacho, Pedro; Elias, Teresa; Otero, Remedios; Ga (2022). Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism. European Respiratory Journal, 59(2), -. DOI: 10.1183/13993003.00412-2021
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2022
    Publication Type: Journal Publications
  • Keywords:

    Medicine (Miscellaneous),Pulmonary and Respiratory Medicine,Respiratory System
    Outpatient
    Mortality
    Early mobilization
    Costs
    Burden
    Saúde coletiva
    Respiratory system
    Pulmonary and respiratory medicine
    Nutrição
    Medicine (miscellaneous)
    Medicina iii
    Medicina ii
    Medicina i
    Interdisciplinar
    General medicine
    Engenharias iv
    Educação física
    Ciências biológicas iii
    Ciências biológicas ii
    Biotecnología
  • Documents:

  • Cerca a google

    Search to google scholar